Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Osteogenesis imperfecta: current concepts (CROSBI ID 482273)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Primorac, Dragan ; Rowe, David ; Mottes, Monica ; Barišić, Ingeborg ; Antičević, Darko ; Mirandola, Stefania ; Gomez Lira, Macarena ; Kalajzić, Ivo ; Kušec, Vesna ; Glorieux, Francis Osteogenesis imperfecta: current concepts // The Second European-American Intensive Course in Clinical and Forensic Genetics / Primorac, Dragan (ur.). Zagreb, 2001. str. 128-x

Podaci o odgovornosti

Primorac, Dragan ; Rowe, David ; Mottes, Monica ; Barišić, Ingeborg ; Antičević, Darko ; Mirandola, Stefania ; Gomez Lira, Macarena ; Kalajzić, Ivo ; Kušec, Vesna ; Glorieux, Francis

engleski

Osteogenesis imperfecta: current concepts

Osteogenesis imperfecta (OI), or brittle bone disease is a heritable disorder characterized by increased bone fragility. Four different types are commonly distinguished that range from a mild condition (type I) to a lethal one (type II). Types III and IV are the severe forms surviving the neonatal period. In most cases, there is a reduction in the production of normal type I collagen or the synthesis of abnormal collagen as a result of mutations in the type I collagen genes. These "classic" forms of OI will be described in this paper in great detail. There are instances, however, where alterations in bone matrix compononents, other than type I collagen, are the basic abnormalities. Recently, three such discrete types have been identified by histomorphometric evaluation (types V and VI)and linkage analysis (Rhizomelic OI). They provide evidence for the as yet poorly understoodcomplexity of the phenotype-genotype correlation in OI. Here will also be discussed a bisphosphonates treatment as well as fracure management and surgical correction of deformities observed in the patients with OI. However, ulimately, strenghthening bone in OI will involve steps to correct the underlying genetic mutations that are responsible for this disorder. In this reviwe we will also give different genetic therapeutic approaches that have been tested either on OI cells or on available OI murine models.

osteogenesis imperfecta; collagen; dentinogenesis imperfecta; mutations; bisphosphonates

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

128-x.

2001.

objavljeno

Podaci o matičnoj publikaciji

The Second European-American Intensive Course in Clinical and Forensic Genetics

Primorac, Dragan

Zagreb:

Podaci o skupu

2nd European-American Intensive course in Clinical and Forensic Genetics

predavanje

03.09.2001-14.09.2001

Dubrovnik, Hrvatska

Povezanost rada

Javno zdravstvo i zdravstvena zaštita